Osaka, Japan

Yoshihiro Terakawa

This inventor holds 4 USPTO granted patents. Top assignees: Mitsubishi Tanabe Pharma Corporation, Tanabe Seiyaku Company, Limited. Active years: 2006-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshihiro Terakawa. Retrieved from https://idiyas.com/inventor/yoshihiro-terakawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2006-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yoshihiro Terakawa: Innovator in Pharmaceutical Compounds

Introduction

Yoshihiro Terakawa is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 4 patents to his name, Terakawa's work has had a meaningful impact on medical science.

Latest Patents

Among his latest patents, Terakawa has developed condensed polycyclic compounds that serve as phosphodiesterase 4 inhibitors. These compounds are represented by a specific formula and can be utilized in pharmaceutical compositions. His innovative approach in this area showcases his commitment to advancing therapeutic options.

Career Highlights

Throughout his career, Yoshihiro Terakawa has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Mitsubishi Tanabe Pharma Corporation and Tanabe Seiyaku Company, Limited. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.

Collaborations

Terakawa has collaborated with esteemed colleagues, including Tatsuzo Ukita and Kazuteru Wada. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Yoshihiro Terakawa's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…